Fluoroquinolone therapy in Mycobacterium chelonae keratitis after lamellar keratectomy

Journal of Cataract and Refractive Surgery

Volumn 31, Issue 7, 2005, Pages 1396-1402

  Sarayba, Melvin A ^a   Shamie, Neda ^a   Reiser, B J ^a   Sweet, Paula M ^a   Taban, Mehran ^a   Graff, Jordan M ^a   Kesler Diaz, Anna ^a   Osann, Kathryn E ^b   McDonnell, Peter J ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BALANCED SALT SOLUTION; CIPROFLOXACIN; GATIFLOXACIN; LEVOFLOXACIN; QUINOLONE DERIVATIVE; ANTIINFECTIVE AGENT; OFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BACTERIUM CULTURE; COLONY FORMING UNIT; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; KERATECTOMY; KERATITIS; MYCOBACTERIUM CHELONEI; NONHUMAN; PRIORITY JOURNAL; RABBIT; ANIMAL; ATYPICAL MYCOBACTERIOSIS; BACTERIAL COUNT; BACTERIAL EYE INFECTION; COMPARATIVE STUDY; CORNEA; CORNEA TRANSPLANTATION; DISEASE MODEL; MICROBIOLOGY; PHYSIOLOGY;

ANIMALS; ANTI-INFECTIVE AGENTS; CIPROFLOXACIN; COLONY COUNT, MICROBIAL; CORNEA; CORNEAL TRANSPLANTATION; DISEASE MODELS, ANIMAL; EYE INFECTIONS, BACTERIAL; FLUOROQUINOLONES; KERATITIS; MYCOBACTERIUM CHELONAE; MYCOBACTERIUM INFECTIONS, ATYPICAL; OFLOXACIN; RABBITS;

EID: 24944461867     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcrs.2004.12.051     Document Type: Article

References (38)

1. Machat JJ. LASIK complications. In: Machat JJ, Slade SG, Probst LE, eds, The Art of LASIK, 2nd ed. Thorofare, NJ, Slack, 1999; 371-415
2. Suarez E, Cardenas J. Intraoperative complications of LASIK. In: Buratto L, Brint SF, eds, LASIK: Principles and Techniques. Thorofare, NJ, Slack, 1998; 371-379
3. Dada T, Sharma N, Dada VK, Vajpayee RB. Pneumococcal keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2000; 26:460-461
4. Mulhern MG, Condon PI, O'Keefe M. Endophthalmitis after astigmatic myopic laser in situ keratomileusis. J Cataract Refract Surg 1997; 23:948-950
5. Kim H-M, Song J-S, Han H-S, Jung H-R. Streptococcal keratitis after myopic laser in situ keratomileusis. Korean J Ophthalmol 1998; 12:108-111
6. Quiros PA, Chuck RS, Smith RE, et al. Infectious ulcerative keratitis after laser in situ keratomileusis. Arch Ophthalmol 1999; 117:1423-1427
7. Webber SK, Lawless MA, Sutton GL, Rogers CM. Staphylococcal infection under a LASIK flap. Cornea 1999; 18:361-365
8. Al-Reefy M. Bacterial keratitis following laser in situ keratomileusis for hyperopia. J Refract Surg 1999; 15:S216-S217
9. Watanabe H, Sato S, Maeda N, et al. Bilateral corneal infection as a complication of laser in situ keratomileusis. Arch Ophthalmol 1997; 115:1593-1594
10. Karp KO, Hersh PS, Epstein RJ. Delayed keratitis after laser in situ keratomileusis. J Cataract Refract Surg 2000; 26:925-928
11. Pérez-Santonja JJ, Sakla HF, Abad JL, et al. Nocardial keratitis after laser in situ keratomileusis. J Refract Surg 1997; 13:314-317
12. Chung MS, Goldstein MH, Driebe WT Jr, Schwartz BH. Mycobacterium chelonae keratitis after laser in situ keratomileusis successfully treated with medical therapy and flap removal. Am J Ophthalmol 2000; 129:382-384
13. Brancato R, Carones F, Venturi E, et al. Mycobacterium chelonae keratitis after excimer laser photorefractive keratectomy. Arch Ophthalmol 1997; 115:1316-1318
14. Reviglio V, Rodriguez ML, Picotti GS, et al. Mycobacterium chelonae keratitis following laser in situ keratomileusis. J Refract Surg 1998; 14:357-360
15. Gelender H, Carter HL, Bowman B, et al. Mycobacterium keratitis after laser in situ keratomileusis. J Refract Surg 2000; 16:191-195
16. Solomon A, Karp CL, Miller D, et al. Mycobacterium interface keratitis after laser in situ keratomileusis. Ophthalmology 2001; 108:2201-2208
17. Read RW, Chuck RSH, Rao NA, Smith RE. Traumatic Acremonium atrogriseum keratitis following laser-assisted in situ keratomileusis. Arch Ophthalmol 2000; 118:418-421
18. O'Brien TP, Matoba AY. Nontuberculous mycobacterial disease. In: Pepose JS, Holland GN, Wilhelmus KR, eds, Ocular Infection & Immunity. St Louis, MO, Mosby Year Book, 1996; 1033-1041
19. Gangadharam PR, Lockhart JA, Awe RJ, Jenkins DE. Mycobacterial contamination through tap water [letter]. Am Rev Respir Dis 1976; 113:894
20. Goslee S, Wolinsky E. Water as a source of potentially pathogenic mycobacteria. Am Rev Respir Dis 1976; 113:287-292
21. Newman PE, Goodman RA, Waring GO III, et al. A cluster of cases of Mycobacterium chelonei keratitis associated with outpatient office procedures. Am J Ophthalmol 1984; 97:344-348
22. Holmes GP, Bond GB, Fader RC, Fulcher SF. A cluster of cases of Mycobacterium szulgai keratitis that occurred after laser-assisted in situ keratomileusis. Clin Infect Dis 2002; 34:1039-1046
23. Pushker N, Dada T, Sony P, et al. Microbial keratitis after laser in situ keratomileusis. J Refract Surg 2002; 18:280-286
24. Alvarenga L, Freitas D, Hofling-Lima AL, et al. Infectious post-LASIK crystalline keratopathy caused by non-tuberculous mycobacteria. Cornea 2002; 21:426-429
25. Seo KY, Lee JB, Lee K, et al. Non-tuberculous mycobacterial keratitis at the interface after laser in situ keratomileusis. J Refract Surg 2002; 18:81-85
26. Garg P, Bansal AK, Sharma S, Vemuganti GK. Bilateral infectious keratitis after laser in situ keratomileusis; a case report and review of the literature. Ophthalmology 2001; 108:121-125
27. Chandra NS, Torres MF, Winthrop KL, et al. Cluster of Mycobacterium chelonae keratitis cases following laser in-situ keratomileusis. Am J Ophthalmol 2001; 132: 819-830
28. Ford JG, Huang AJW, Pflugfelder SC, et al. Nontuberculous mycobacterial keratitis in south Florida. Ophthalmology 1998; 105:1652-1658
29. Smith A, Pennefather PM, Kaye SB, Hart CA. Fluoroquinolones: places in ocular therapy. Drugs 2001; 61:747-761
30. Drlica K. A strategy for fighting antibiotic resistance. Am Soc Microbiol News 2001; 67:27-33
31. Courvalin P, Depardieu F. The influence of antibacterial mechanisms of action on the emergence, dissemination, and prevention of resistance. In: Pankey GA, Campbell SD Jr, eds, Ochsner Clinic Symposium on Resistance and the Use and Misuse of Antimicrobial Therapy. Newton, PA, Associates in Medical Marketing, 2000; 15-22
32. Mather R, Karenchak LM, Romanowski EG, Kowalski RP. Fourth generation fluoroquinolones: new weapons in the arsenal of ophthalmic antibiotics. Am J Ophthalmol 2002; 133:463-466
33. Rao SN, Fong Y-C, Kampmeier J, et al. The effectiveness of a topical antibiotic irrigating solution in a model of staphylococcal keratitis after lamellar keratectomy. Am J Ophthalmol 2000; 130:20-24
34. McDonnell PJ. Emergence of refractive surgery. Arch Ophthalmol 2000; 118:1119-1120
35. Lin RT, Maloney RK. Flap complications associated with lamellar refractive surgery. Am J Ophthalmol 1999; 127:129-136
36. Tuft SJ, Matheson M. In vitro antibiotic resistance in bacterial keratitis in London. Br J Ophthalmol 2000; 84:687-691
37. Abshire R, Cockrum P, Crider J, Schlech B. Topical antibacterial therapy for mycobacterial keratitis: potential for surgical prophylaxis and treatment. Clin Ther 2004; 26:191-196
38. Hyon J-Y, Joo M-J, Hose S, et al. Comparative efficacy of topical gatifloxacin with ciprofloxacin, amikacin, and clarithromycin in the treatment of experimental Mycobacterium chelonae keratitis. Arch Ophthalmol 2004; 122:1166-1169